These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 28100620

  • 1. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
    Li Y, Zhou M, Luo Z, Zhang Y, Cui M, Chen H, Fu ZF, Zhao L.
    J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28100620
    [Abstract] [Full Text] [Related]

  • 2. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells.
    Wang Z, Li M, Zhou M, Zhang Y, Yang J, Cao Y, Wang K, Cui M, Chen H, Fu ZF, Zhao L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27852854
    [Abstract] [Full Text] [Related]

  • 3. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L, Yan L, Zheng W, Lei X, Fu Q, Xue X, Wang X, Xia X, Zheng X.
    Vet Microbiol; 2021 Jun 01; 257():109076. PubMed ID: 33957572
    [Abstract] [Full Text] [Related]

  • 4. Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs.
    Chen C, Zhang C, Li H, Wang Z, Yuan Y, Zhou M, Fu ZF, Zhao L.
    J Virol; 2021 Nov 23; 95(24):e0082921. PubMed ID: 34613801
    [Abstract] [Full Text] [Related]

  • 5. Investigating the role for IL-21 in rabies virus vaccine-induced immunity.
    Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP.
    PLoS Negl Trop Dis; 2013 Nov 23; 7(3):e2129. PubMed ID: 23516660
    [Abstract] [Full Text] [Related]

  • 6. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.
    Haley SL, Tzvetkov EP, Meuwissen S, Plummer JR, McGettigan JP.
    J Virol; 2017 Apr 15; 91(8):. PubMed ID: 28148792
    [Abstract] [Full Text] [Related]

  • 7. Over-expression of IL-33 enhances rabies virus early antigen presentations and cellular immune responses in mice.
    Liu L, Zheng W, Qian H, Zhao Z, Tian L, Song Y, Lei X, Zhao Z, Xue X, Zheng X.
    Int Immunopharmacol; 2023 Nov 15; 124(Pt B):111005. PubMed ID: 37804656
    [Abstract] [Full Text] [Related]

  • 8. Colloidal Manganese Salt Improves the Efficacy of Rabies Vaccines in Mice, Cats, and Dogs.
    Wang Z, Yuan Y, Chen C, Zhang C, Huang F, Zhou M, Chen H, Fu ZF, Zhao L.
    J Virol; 2021 Nov 09; 95(23):e0141421. PubMed ID: 34495701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
    Liu C, Li J, Yao Q, Gao Z, Cheng Y, Zhou M, Tang Y, Sun L, Dai J, Cao G, Zhang XL, Zhang R.
    Vet Microbiol; 2020 Mar 09; 242():108578. PubMed ID: 32122589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats and dogs.
    Meng X, Yan F, Wang W, Wang S, Cong H, Li J, Zhao Y, Wang T, Li N, Gao Y, Wang J, Feng N, Xia X.
    Emerg Microbes Infect; 2024 Dec 09; 13(1):2406280. PubMed ID: 39295522
    [Abstract] [Full Text] [Related]

  • 13. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J, Sun J, Ding X, Liu W, Wang Y, Wang Z, Peng H, Zhang Y, Su W, Jiang C.
    Emerg Microbes Infect; 2024 Dec 09; 13(1):2389115. PubMed ID: 39129566
    [Abstract] [Full Text] [Related]

  • 14. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.
    Chen C, Zhang C, Li R, Wang Z, Yuan Y, Li H, Fu Z, Zhou M, Zhao L.
    Viruses; 2019 Dec 03; 11(12):. PubMed ID: 31816996
    [Abstract] [Full Text] [Related]

  • 15. Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal centre B cells.
    Zhang Y, Zhou M, Wang Z, Yang J, Li M, Wang K, Cui M, Chen H, Fu ZF, Zhao L.
    J Gen Virol; 2016 Dec 03; 97(12):3154-3160. PubMed ID: 27902338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C, Tian Y, Chen C, Wang Z, Pei J, Lin C, Zhou M, Fu ZF, Zhao L.
    J Virol; 2021 Sep 27; 95(20):e0079021. PubMed ID: 34346765
    [Abstract] [Full Text] [Related]

  • 18. APRIL:TACI axis is dispensable for the immune response to rabies vaccination.
    Haley SL, Tzvetkov EP, Lytle AG, Alugupalli KR, Plummer JR, McGettigan JP.
    Antiviral Res; 2017 Aug 27; 144():130-137. PubMed ID: 28619678
    [Abstract] [Full Text] [Related]

  • 19. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR, McGettigan JP.
    PLoS Negl Trop Dis; 2019 Nov 27; 13(11):e0007800. PubMed ID: 31725816
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-25 enhances humoral immune responses caused by the rabies virus.
    Zhang Y, Zhang M, Liao X, Yu Y, Liu Q, Luo Y, Luo J, Guo X.
    Virulence; 2022 Dec 27; 13(1):1446-1454. PubMed ID: 35999776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.